Synthetic Cannabinoids (Qualitative) (2019 Scope), Serum/Plasma

Method(s)

High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

Suggested CPT Code(s)

80352x2

New York State Approval Status

Approved

Turnaround Time

7 days

Test Includes


1	5-fluoro-MMB-PINACA	5-fluoro AMB; methyl ester; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.05	Synthetic Cannabinoid
2	CUMYL-THPINACA	N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
3	MDMB-FUBICA	methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-3-methyl-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
4	MMB-FUBINACA	FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
5	5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA	5F-ADB/5F-AEB; methyl ester/ ethyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.2	Synthetic Cannabinoid
6	MMB-FUBICA	methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
7	MDMB-FUBINACA / EMB-FUBINACA	1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate/ ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
8	5-fluoro-EDMB-PINACA	ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
9	NA-FUBIM	(1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone; FUB-JWH-018	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
10	5-fluoro-QU-PINAC	1-(5-fluoropentyl)-8-quinolinyl ester-1H-indazole-3-carboxylic acid; 5-fluoro NPB 22	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
11	MMB-CHMICA	methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
12	NA-FUBIC	1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 1-naphthalenyl ester; FDU-PB-22	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
13	MDMB-CHMICA	methyl ester; N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
14	5-fluoro-NA-PIC	naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; NM-2201	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
15	MMB-CHMINACA	MA-CHMINACA; methyl (1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)-L-valinate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.2	Synthetic Cannabinoid
16	MDMB-CHMINAC	MO-CHMINACA; N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
17	ADAMANTYL-FUBINACA	FUB-AKB48; N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.2	Synthetic Cannabinoid
18	MDMB-CHMCZCA	methyl (S)-2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
19	AMB-FUBINACA	N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
20	ADMB-FUBINACA	ADB-FUBINACA; N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
21	ADMB-FUBICA	ADB-FUBICA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
22	4-cyano-CUMYL-BINACA	1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
23	AMB-CHMINACA	AB-CHMINACA; N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
24	4-fluoro-MDMB-BINACA	4-fluoro-MDMB-BUTINACA; methyl (S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
25	5-fluoro-MDMB-PICA	methyl ester; N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
26	ADMB-CHMINACA	ADB-CHMINACA; MAB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid

Test Also Known As

K2; Spice; Synthetic Cannabinoid

Compliance Statement

This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.

Sample Type

Serum or Plasma

Requested Volume

Minimum Volume

1.4 mL

Special Handling

Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.

Sample Container

Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature

Refrigerated

Light Protection

Not Required

Rejection Criteria

Received Room Temperature. Polymer gel separation tube (SST or PST).

Rejection criteria pertain to clinical sample submissions only.

Stability

Room Temperature: 2 day(s)
Refrigerated: 14 day(s)
Frozen (-20 °C): 14 day(s)


1	5-fluoro-MMB-PINACA	5-fluoro AMB; methyl ester; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.05	Synthetic Cannabinoid
2	CUMYL-THPINACA	N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
3	MDMB-FUBICA	methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-3-methyl-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
4	MMB-FUBINACA	FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
5	5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA	5F-ADB/5F-AEB; methyl ester/ ethyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.2	Synthetic Cannabinoid
6	MMB-FUBICA	methyl ester; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
7	MDMB-FUBINACA / EMB-FUBINACA	1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate/ ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
8	5-fluoro-EDMB-PINACA	ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
9	NA-FUBIM	(1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone; FUB-JWH-018	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
10	5-fluoro-QU-PINAC	1-(5-fluoropentyl)-8-quinolinyl ester-1H-indazole-3-carboxylic acid; 5-fluoro NPB 22	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
11	MMB-CHMICA	methyl (1-(cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
12	NA-FUBIC	1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 1-naphthalenyl ester; FDU-PB-22	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
13	MDMB-CHMICA	methyl ester; N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
14	5-fluoro-NA-PIC	naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; NM-2201	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
15	MMB-CHMINACA	MA-CHMINACA; methyl (1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)-L-valinate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.2	Synthetic Cannabinoid
16	MDMB-CHMINAC	MO-CHMINACA; N-(1-methyl-1-phenylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
17	ADAMANTYL-FUBINACA	FUB-AKB48; N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.2	Synthetic Cannabinoid
18	MDMB-CHMCZCA	methyl (S)-2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
19	AMB-FUBINACA	N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
20	ADMB-FUBINACA	ADB-FUBINACA; N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
21	ADMB-FUBICA	ADB-FUBICA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
22	4-cyano-CUMYL-BINACA	1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
23	AMB-CHMINACA	AB-CHMINACA; N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	1	Synthetic Cannabinoid
24	4-fluoro-MDMB-BINACA	4-fluoro-MDMB-BUTINACA; methyl (S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
25	5-fluoro-MDMB-PICA	methyl ester; N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid
26	ADMB-CHMINACA	ADB-CHMINACA; MAB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	ng/mL	0.1	Synthetic Cannabinoid

Example Report (Negative)

Example Report (Positive)

Interface Map

4282SP Synthetic Cannabinoids (Qualitative) (2019 Scope), Serum/Plasma - Current Version
Analyte	Units	Analyte Mapping Code
5-fluoro-MMB-PINACA	ng/mL	SYC2-5FMMBP
CUMYL-THPINACA	ng/mL	SYC2-CTHP
MDMB-FUBICA	ng/mL	SYC2-MDMBF
MMB-FUBINACA	ng/mL	SYC2-MBFUB
5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA	ng/mL	SYC2-5FEMB
MMB-FUBICA	ng/mL	SYC2-MMBF
MDMB-FUBINACA / EMB-FUBINACA	ng/mL	SYC2-EMBF
5-fluoro-EDMB-PINACA	ng/mL	SYC2-5FEDP
NA-FUBIM	ng/mL	SYC2-NAFUB
5-fluoro-QU-PINAC	ng/mL	SYC2-5FNPB
MMB-CHMICA	ng/mL	SYC2-CHMIC
NA-FUBIC	ng/mL	SYC2-FDB22
MDMB-CHMICA	ng/mL	SYC2-MDMBC
5-fluoro-NA-PIC	ng/mL	SYC2-5FNAP
MMB-CHMINACA	ng/mL	SYC2-MMBC
MDMB-CHMINAC	ng/mL	SYC2-MDBC
ADAMANTYL-FUBINACA	ng/mL	SYC2-AYFUB
MDMB-CHMCZCA	ng/mL	SYC2-CHMCZ
AMB-FUBINACA	ng/mL	SYC3-AMBF
ADMB-FUBINACA	ng/mL	SYC3-ADMBF
ADMB-FUBICA	ng/mL	SYC3-5FADB
4-cyano-CUMYL-BINACA	ng/mL	SYC3-4CYCB
AMB-CHMINACA	ng/mL	SYC3-AMBC
4-fluoro-MDMB-BINACA	ng/mL	SYC3-4FMDMB
5-fluoro-MDMB-PICA	ng/mL	SYC3-5FMDMB
ADMB-CHMINACA	ng/mL	SYC3-ADMBC

4282SP Synthetic Cannabinoids (Qualitative) (2019 Scope), Serum/Plasma - **Effective 02/07/2022**
Analyte	Units	Analyte Mapping Code
ADMB-FUBINACA	ng/mL	ADMBFUBIQL
5-fluoro-PICA 3,3-dimethylbutanoic acid	ng/mL	5PICA33DQL
5-fluoro-PINACA 3-methylbutanoic acid	ng/mL	5PINACA3QL
4-fluoro-BINACA 3,3-dimethylbutanoic acid	ng/mL	4FB33DMBQL
FUBINACA 3-methylbutanoic acid	ng/mL	FUBINA3MQL
5-fluoro-PINACA 3,3-dimethylbutanoic acid	ng/mL	5FPN33DMQL
FUBINACA 3,3-dimethylbutanoic acid	ng/mL	FUBN33DBQL
APP-BINACA	ng/mL	APPBINACQL
5-fluoro-MDMB-PICA / 5-fluoro-EMB-PICA	ng/mL	5FEMBPCAQL
MMB-FUBINACA	ng/mL	MMBFUCINQL
5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA	ng/mL	5FEMBPINQL
MDMB-4en-PINACA	ng/mL	MDMB4ENPQL
ADMB-CHMINACA	ng/mL	ADMBCHMIQL
4-fluoro-MDMB-BINACA	ng/mL	4FMDMBINQL

4282SP Synthetic Cannabinoids (Qualitative) (2019 Scope), Serum/Plasma - **Effective 04/04/2022**
Analyte	Units	Analyte Mapping Code
ADMB-FUBINACA	ng/mL	ADMBFUBIQL
5-fluoro-PICA 3,3-dimethylbutanoic acid	ng/mL	5PICA33DQL
5-fluoro-PINACA 3-methylbutanoic acid	ng/mL	5PINACA3QL
4-fluoro-BINACA 3,3-dimethylbutanoic acid	ng/mL	4FB33DMBQL
FUBINACA 3-methylbutanoic acid	ng/mL	FUBINA3MQL
5-fluoro-PINACA 3,3-dimethylbutanoic acid	ng/mL	5FPN33DMQL
FUBINACA 3,3-dimethylbutanoic acid	ng/mL	FUBN33DBQL
APP-BINACA	ng/mL	APPBINACQL
5-fluoro-MDMB-PICA / 5-fluoro-EMB-PICA	ng/mL	5FEMBPCAQL
MMB-FUBINACA	ng/mL	MMBFUCINQL
5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA	ng/mL	5FEMBPINQL
MDMB-4en-PINACA	ng/mL	MDMB4ENPQL
ADMB-CHMINACA	ng/mL	ADMBCHMIQL
4-fluoro-MDMB-BINACA	ng/mL	4FMDMBINQL

LOINC^® Information

4282SP Synthetic Cannabinoids (Qualitative) (2019 Scope), Serum/Plasma - Current Version
Analyte	Units	Analyte Mapping Code
5-fluoro-MMB-PINACA	ng/mL	SYC2-5FMMBP
CUMYL-THPINACA	ng/mL	SYC2-CTHP
MDMB-FUBICA	ng/mL	SYC2-MDMBF
MMB-FUBINACA	ng/mL	SYC2-MBFUB
5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA	ng/mL	SYC2-5FEMB
MMB-FUBICA	ng/mL	SYC2-MMBF
MDMB-FUBINACA / EMB-FUBINACA	ng/mL	SYC2-EMBF
5-fluoro-EDMB-PINACA	ng/mL	SYC2-5FEDP
NA-FUBIM	ng/mL	SYC2-NAFUB
5-fluoro-QU-PINAC	ng/mL	SYC2-5FNPB
MMB-CHMICA	ng/mL	SYC2-CHMIC
NA-FUBIC	ng/mL	SYC2-FDB22
MDMB-CHMICA	ng/mL	SYC2-MDMBC
5-fluoro-NA-PIC	ng/mL	SYC2-5FNAP
MMB-CHMINACA	ng/mL	SYC2-MMBC
MDMB-CHMINAC	ng/mL	SYC2-MDBC
ADAMANTYL-FUBINACA	ng/mL	SYC2-AYFUB
MDMB-CHMCZCA	ng/mL	SYC2-CHMCZ
AMB-FUBINACA	ng/mL	SYC3-AMBF
ADMB-FUBINACA	ng/mL	SYC3-ADMBF
ADMB-FUBICA	ng/mL	SYC3-5FADB
4-cyano-CUMYL-BINACA	ng/mL	SYC3-4CYCB
AMB-CHMINACA	ng/mL	SYC3-AMBC
4-fluoro-MDMB-BINACA	ng/mL	SYC3-4FMDMB
5-fluoro-MDMB-PICA	ng/mL	SYC3-5FMDMB
ADMB-CHMINACA	ng/mL	SYC3-ADMBC

4282SP Synthetic Cannabinoids (Qualitative) (2019 Scope), Serum/Plasma - **Effective 02/07/2022**
Analyte	Units	Analyte Mapping Code
ADMB-FUBINACA	ng/mL	ADMBFUBIQL
5-fluoro-PICA 3,3-dimethylbutanoic acid	ng/mL	5PICA33DQL
5-fluoro-PINACA 3-methylbutanoic acid	ng/mL	5PINACA3QL
4-fluoro-BINACA 3,3-dimethylbutanoic acid	ng/mL	4FB33DMBQL
FUBINACA 3-methylbutanoic acid	ng/mL	FUBINA3MQL
5-fluoro-PINACA 3,3-dimethylbutanoic acid	ng/mL	5FPN33DMQL
FUBINACA 3,3-dimethylbutanoic acid	ng/mL	FUBN33DBQL
APP-BINACA	ng/mL	APPBINACQL
5-fluoro-MDMB-PICA / 5-fluoro-EMB-PICA	ng/mL	5FEMBPCAQL
MMB-FUBINACA	ng/mL	MMBFUCINQL
5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA	ng/mL	5FEMBPINQL
MDMB-4en-PINACA	ng/mL	MDMB4ENPQL
ADMB-CHMINACA	ng/mL	ADMBCHMIQL
4-fluoro-MDMB-BINACA	ng/mL	4FMDMBINQL

4282SP Synthetic Cannabinoids (Qualitative) (2019 Scope), Serum/Plasma - **Effective 04/04/2022**
Analyte	Units	Analyte Mapping Code
ADMB-FUBINACA	ng/mL	ADMBFUBIQL
5-fluoro-PICA 3,3-dimethylbutanoic acid	ng/mL	5PICA33DQL
5-fluoro-PINACA 3-methylbutanoic acid	ng/mL	5PINACA3QL
4-fluoro-BINACA 3,3-dimethylbutanoic acid	ng/mL	4FB33DMBQL
FUBINACA 3-methylbutanoic acid	ng/mL	FUBINA3MQL
5-fluoro-PINACA 3,3-dimethylbutanoic acid	ng/mL	5FPN33DMQL
FUBINACA 3,3-dimethylbutanoic acid	ng/mL	FUBN33DBQL
APP-BINACA	ng/mL	APPBINACQL
5-fluoro-MDMB-PICA / 5-fluoro-EMB-PICA	ng/mL	5FEMBPCAQL
MMB-FUBINACA	ng/mL	MMBFUCINQL
5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA	ng/mL	5FEMBPINQL
MDMB-4en-PINACA	ng/mL	MDMB4ENPQL
ADMB-CHMINACA	ng/mL	ADMBCHMIQL
4-fluoro-MDMB-BINACA	ng/mL	4FMDMBINQL

Some LOINC^® codes may not have been assigned or are not available.

This material contains content from LOINC (http://loinc.org). LOINC is copyright ^® 1995-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC^® is a registered United States trademark of Regenstrief Institute, Inc.

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.